Daiichi Sankyo Co. Ltd. Registered Shares o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

30.13%

Market Cap

27.24 Bil.

P/E Ratio

19.69

Dividend Yield

2.82 %

Earnings per Share

0.81 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE15.312 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 04:33:05 PM
DAILY VOLUME (UNITS)400
DAILY HIGH / LOW15.49614.996
PREV. DAY'S PRICE14.968 (07/20)
CHANGE DAY BEFORE
+0.34
2.30 %
52 WEEK HIGH / LOW23.37 (10/09)12.834 (06/04)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.670.950.810.841.03
DIVIDENDS PER SHARE
0.320.370.450.540.59
DIVIDEND YIELD IN %
1.05 %1.71 %2.82 %--
DIVIDEND GROWTH IN %
49.70 %14.87 %21.80 %--
PRICE - EARNINGS RATIO
45.6322.5119.6917.9014.52
PRICE - BOOK RATIO
5.434.043.02--
PRICE - SALES RATIO
5.723.532.41--
PRICE - CASH FLOW RATIO
15.29123.7365.94--
Further Key Figures

Master Data

WKN
A0F57T
ISIN
JP3475350009
SYMBOL
D4S
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
DaiichiSankyo
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Japanese Yen
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
1.82 Bil.
MARKET CAPITALISATION
27.24 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.05 %
4.57 %
-6.73 %
-18.85 %
-30.13 %
-41.34 %
-13.83 %
-18.72 %
HIGH15.5615.5616.1918.0023.3737.6437.6419.74
LOW14.3013.5412.8312.8312.8312.8312.8312.83

Dividende

pro Aktie

Company profile

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.